Tthe efficacy and safety of drug therapy divaza in patients with chronic cerebral ischemia

Close metadata

Recommended articles:

Integrative assessment of the effectiveness and safety of outpatient use of Picamilon. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):119-130

Significance of immunological markers in patients with obstructive sleep apnea and comorbid pathology. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):47-53

Clinical efficacy and safety of Picamilon in patients with progressive chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):71-80

Modern aspects of chronic cerebral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113

Surgical treatment of congenital and acquired internal carotid artery tortuosity in patients with ocular ischemic syndrome. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):272-278

Efficacy of different postural control training in elderly people with chronic cerebral ischemia. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(2):42-48

International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO): subanalysis in patients with arterial hypertension. Russian Journal of Preventive Medicine. 2024;(10):72-83

Resolution of the expert council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders». Russian Journal of Preventive Medicine. 2024;(11):85-93

Objective. To evaluate the efficacy and safety of divazа in the treatment of cognitive and emotional disorders in patients with chronic cerebral ischemia (CCI) based on clinical findings and laboratory markers of endothelial dysfunction. Material and methods. Thirty patients with CCI, aged 40 to 70 years, were examined. All patients were treated with divazа (2 tablets 3 times a day) for 12 weeks. Cognitive functions and markers of endothelial dysfunction (the activity of endothelial NO-synthase (eNOS), the number of circulating desquamated endothelial cells in blood plasma) were measured at baseline and after treatment. Results. Divazа significantly reduced the severity of clinical symptoms and had a positive effect on endothelial dysfunction normalizing the tone of cerebral vessels and preventing deendotheliazation. Conclusion. The use of divazа resulted in clinical improvement and normalization of markers of endothelial dysfunction as well.

Keywords:

chronic cerebral ischemia

laboratory markers of endothelial dysfunction

the activity of endothelial NO-synthase

circulating desquamated endothelial cells

Divaza

Authors:

Fateeva V.V.

Sechenov First Мoscow State Medical University, Moscow, Russia

Shumacher G.I.

Altai State Medical University, Barnaul

Vorobyova E.N.

Barnaul Multidisciplinary Medical Center «Isida», Barnaul, Russia

Horeva M.A.

Altai State Medical University, Barnaul, Russia

Voskanyan L.R.

Altai State Medical University, Barnaul, Russia

List of references:

Skvortsova V.I. Snizhenie morbidity, mortality and disability from stroke in the Russian Federation. 2008;194. (In Russ.).
Damulin IV, Parfenov VA, Skoromets AA NN Yahno. Disorders of blood circulation in the brain and spinal cord. In the book: «Diseases of the nervous system. Guidelines for doctors». Eds. Yahno NN, Shtulman DR. M.: Meditsina; 2005. (In Russ.).
Skvortsova VI, Evzelman MA Ischemic stroke. Orel. 2006;404. (In Russ.).
Gusev EI, Martynov MYu, Yasamanova AN, Kolesnikova TI, Kabanov AA, Petukhov EB, Berezov VP. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2001;1:41-45. (In Russ.).
Kadykov AS, Manvel LS, Shahparonova NV. Chronic vascular diseases of the brain: encephalopathy: a guide for physicians. 3-e izd., pererab. i dop. M.: GEOTAR-Media; 2014. (In Russ.).
Afanasiev VV, Rumyantsev SA, Silin EV. Pathophysiology and Therapy tektivnaya neyropro-ischemic brain damage. Meditsinskii Sovet. 2008;9-10:35-39. (In Russ.).
Oganov RG. The concept of risk factors as a basis for the prevention of cardiovascular diseases. Vrach. 2001;7:3-7. (In Russ.).
Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: A Guideline from the American Heart Association/American Stroke Association Stroke Council : Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:1583-1633. doi:10.1161/01.str.0000223048.70103.f1
Gusev EI, Chukanova AS. Modern pathogenetic aspects of the formation of chronic brain ischemia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;3:4-8. (In Russ.).
Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, Age, Cardiovascular Risk Factors, and coronary heart disease: A Prospective Follow-Up Study of 14786 Middle-Aged Men and Women in Finland. Circulation. 1999;99:9:1465-1472. doi:10.1161/01.cir.99.9.1165
Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109:27-33. doi:10.1161/01.CIR.0000129501.88485.1f
Viktorov IV. The role of nitric oxide and other free radicals in cerebral ischemic pathology. Vestnik RAMN. 2004;4:5-10. (In Russ.).
Malyshev IY, Collegiate EA, Smirin BV, Manukhina EB. Hypoxia and nitric oxide. Vestnik RAMN. 2000;9:44-48. (In Russ.).
Gorbachev VI, Kovalev VV. The role of nitric oxide in the pathogenesis of lesions of the central nervous system dameges. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (Prilozhenie «Insul't»). 2002;7:9-16. (In Russ.).
Forstermann U, Biossel J-P, Kleinert H. Expressional control of the «constitutive isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998;12:773-790.
Manukhina EB, Malyshev IYu, Smirin BV, Mashina SYu, Saltykova VA, Vanin AF. Production and storage of nitric oxide in adaptation to hypoxia. Nitric Oxide. 1999;3:393-401. doi:10.1006/niox.1999.0244
Neubauer JA. Physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol. 2001;90:1593-1599. doi:10.1016/j.resp.2008.10.012
Li H, Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol. 2000;90:244-254. doi:10.1111/j.1476-5381.2010.01196.x
Nechipurenko NI, Pashkovskaya ID, Musienko YuI. Basic pathophysiological mechanisms of cerebral ischemia. Meditsinskie novosti. 2008;1:7-13. (In Russ.).
Hladovec J. Circulating endothelial cells as sign of vessel wall lesions. Physiol Bohemoslov. 1978;27(2):140-144.
Trailin AV, Levada OA Protein S100B: neuroscience, the value in neurological and psychiatric pathology. Mezhdunarodnyi nevrologicheskii zhurnal. 2009;3:1(23):166-172. (In Russ).
Nishiyama H, Knopfel T, Endo S, Itohara S. Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc Natl Acad Sci USA. 2002;99:4037-4042. doi:10.1073/pnas.052020999
Selinfreud RH, Barger SW, Pledger WJ, Van Eldik LJ. Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc Natl Acad Sci USA. 1991;88:3554-2558. doi:10.1073/pnas.88.9.3554
Van Eldik LJ, Christie-Pope B, Bolin LM, Shooter EM, Whetsell WO. Neurotrophic activity of S-100β in cultures of dorsal root ganglia from embryonic chick and fetal rat. Brain Res. 1991;542:280-285. doi:10.1016/0006-8993(91)91579-p
Reeves RH, Yao J, Crowley MR, Buck S, Zhang X, Yarowsky P, Gearhart JD, Hilt DC. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc Natl Acad Sci USA. 1994;91:5359-5363. doi:10.1073/pnas.91.12.5359
Brewton LS, Haddad L, Azmitia EC. Colchicine-induced cytoskeletal collapse and apoptosis in N-18 neuroblastoma cultures israpidly reversed by applied S-100β. Brain Res. 2001;912:9-16. doi:10.1016/j.bbamcr.2007.01.003
Kamchatnov PR, Vorobyov OV, Rachin AP. Treatment of emotional and cognitive disorders in patients with chronic cerebral ischemia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014;4:52-56. (In Russ.).
Abdurasulova IN, Mukhin VN, Klimenko VM, Zhavbert ES, Dugina YuL. Comparative study of the efficacy tenoten, Impaza and Divazy model of beta-amyloid amnesia in rats. Materialy XXI Rossiiskogo natsional'nogo kongressa «Chelovek i lekarstvo». M. 2014;191. (In Russ.).
Denisova TD, Salikova LR, Lebedeva SA, Tekutova TV, Bugaeva LI, Petrov VI, Gur'yanova NN, Dugina YuL. Effect of tenoten Divazy and the duration of hexenal sleep male rats in chronic Materials Science Experiment. Materialy XXI Rossiiskogo natsional'nogo kongressa «Chelovek i lekarstvo». M. 2014;234. (In Russ.).
Zhavbert KH, Guryanov NN, Surkov EI, Dugina YuL, Kachaeva EV, Epshtein OI, Myshkin VA, Gurto RV. A study on the impact of Divazy lipid peroxidation. Proceedings of the XXI Russian National Congress «Man and medicine». M. 2014;242. (In Russ.).
Heifetz IA, Voronina TA, Molodavkin GM, Dugina YuL. Experimental study of anxiolytic antidepressant drug action Divaza. Materialy VIII mezhdunarodnogo mezhdistsiplinarnogo kongressa «Neironauka dlya meditsiny i psikhologii». Sudak. 2012. (In Russ.).
Schmidt EV. Classification of vascular brain and spinal cord injuries. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1985;9:1281-1288. (In Russ.).
Zakharov VV. Neuropsychological tests. The need and opportunity to use. Consilium medicum. 2011;13:2:82-90. (In Russ.).
Zakharov VV, Yahno NN. Cognitive disorders in elderly and senile age. M. 2005. (In Russ.).
Manukhina EB, Malyshev IYu. The role of nitric oxide in the development and prevention of endothelial dysfunction. Vestnik VGMU. 2003;2:2:5-18. (In Russ.).
Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL. AHA/ASA Scientific Statement Definition and Evaluation of Transient Ischemic Attack. Stroke. 2009;40:2276-2293.
European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovascular Diseases. 2008;25:457-507. doi:10.1159/000131083

Close metadata